🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/TZ-2026-053Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Tirzepatide 15 mg

TZ-2026-053Lot ARTBLKTR15OCTAnalyzed November 11, 2026
Tirzepatide 15 mg vial as received

Timeline

Ordered
November 4, 2026
Received
November 10, 2026
Analyzed
November 11, 2026

Sample

Name
Tirzepatide 15 mg
Expected
Tirzepatide
Amount
1 vial, lyophilized powder

Testing

Client
4Ever Research
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
18.19mg
Label claim: 15 mg
Purity, how clean it is
>99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold. Results of 99.95% or higher are reported as >99.9%, as 100% purity cannot be demonstrated analytically.

Chromatogram

HPLC-UV

mAU-10001002000481216202428Retention time (min)19.14
19.14 min, Tirzepatide, >99.9%

Analyst Comments

White lyophilized powder, black-cap vial, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 11, 2026

Verification Code

TZ-1APV-08HV
Verify at purilab.org/verify/TZ-1APV-08HV

Scan to Verify

TZ-1APV-08HV

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1